Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 15

MOUNT LITERA ZEE SCHOOL

BHAGABATIPUR, BHUBANESWAR

BIOLOGY PROJECT

SESSION: 2023-2024
A PROJECT REPORT ON

“COVID-19”

SUBMITETED BY:
SWAYAMSHREE
CLASS – XII (SCIENCE)
ROLL NO:12655050 Under the Guidance of

Soubhagya Ranjan Chakrabarty

PGT(Biology)
MOUNT LITERA ZEE SCHOOL, BHUBANESWAR

CERTIFICATE
This is to certify that SWAYAMSHREE, student of class XII
(Science) has successfully prepared the report on the project entitled
“Covid-19” under the guidance of MR. SOUBHAGYA RANJAN
CHAKRABARTY (PGT Biology).
This report is the result of her efforts and endeavors.
The report is found worthy of acceptance as final project report for
the subject Biology of class XII (science).

Signature of Internal Examiner Signature of External Examiner

Principal’s Signature
DECLRATION
I hereby declare that the project work entitled, “Covid-19” submitted to
Department of Biology , Mount Litera Zee School, Bhubaneswar is
prepared by me.

Swayamshree

Class – XII (Science)

Roll No.-12655050
ACKNOWLEDGEMENT

I would like to express a deep sense of thanks and gratitude to my project guide
Soubhagya Ranjan Chakrabarty for guiding me immensely through the course
of the project. He always evinced keen interest in my project. His constructive
advice and constant motivation have been responsible for the successful
completion of this project.

My sincere thank goes to Dr. Sudhansu Kumar Sahu (Principal) and Miss Mitali
Rani Chakrabarty (Vice-Principal) for his co-ordination in extending every
possible support for the completion of this project.

I must thank my classmates for their timely help and support for completion of
this project.

Last but not the least; I would like to thank all those who had helped directly or
indirectly towards the completion of this project.

Swayamshree

Class – XII (Science)

Roll No.- 12655050


INDEX

SL NO. CONTENT PAGE NO.

01. INTRODUCTION 1

02. HOSTS , RESERVOIRS AND INFECTED 2


ANIMALS

03. INCUBATION PERIOD 3

04. DIAGONSTIC TEST 4

05. COVID-19 SYMPTOMS 5

06. TREATMENTS 6

07. PREVENTIONS 7

08. BIBLIOGRAPHY 8
INTRODUCTION
 Covid 19 causes acute respiratory syndrome.

 The first case was reported in Wuhan,China in


December 2019.

 The disease spreaded world wide and became


pandemic.
Hosts, Reservoirs and Infected
Animals
 Infect birds and mammals.

 Bats are hosts to the largest number of viral genotypes of


coronavirus.

 Epidemics can occur when viruses transmit from one


species to another.

 Can cause mutations in proteins that allow viruses to bind


to cells.

Humans
 Human coronaviruses are causes of respiratory and
gastrointestinal tract infections.

 Estimated to account for 5-10 percent of all adult upper


respiratory tract infections (“common cold” to pneumonia and
ARDS).

 GI symptoms including diarrhea.

 When mutations occur, coronaviruses can be a significant


cause of human epidemics.
INCUBATION PERIOD

The incubation period of COVID-19, which is


the time between exposure to the virus and
symptom onset, is on average 5-6 days, but
can be as long as 14 days. Thus, quarantine
should be in place for 14 days from the last
exposure to a confirmed.
DIAGNOSTIC TESTS
Antibody (Serology) Tests

What they do: These tests detect antibodies that signal that
the body has mounted an immune response to the virus.
They do not indicate whether a person has current COVID-
19 infection, or when they were exposed.
Method: Blood Sample
Molecular Tests
What they do: These tests loo for the virus’s genetic
material and are the current standard for diagnosing COVID-
19.
Method: Nasal or throat swab, and for some test, saliva.
COVI
D-19 SYMPTOMS

Fever or chills
 Cough
 Shortness of breath or difficulty in breathing
 Fatigue
 Muscle or body aches
 Headache
 New loss of taste or smell
 Sore throat
 Congestion or runny nose
 Nausea or vomiting
 Diarrhea
TREATMENTS
There is no specific, effective treatment or cure for corona viruses’ disease
2019 (COVID-19) the disease caused by the SARSCOVID-2 virus.

 But in India “Covishield” and “Covaxin” were used in this time.

 The “Oxford –AstraZeneca” vaccine has been approved for use


in the UK. There is no vaccine approved by WHO.
PREVENTION
 Wash hands even if they are visibly clean.

 To cover your nose and mouth with


handkerchief/tissue while sneezing and coughing.

 To throw used tissues into closed bins


immediately after use.

 To maintain a safe distance from persons during


interaction, especially with those having flu-like
symptoms.
bibliography

1. Google
 https://www.webmd.com
 https://www.who.int
 https://www.narayanahealth.org
2. YouTube
3. Biology Teacher
THANKYOU

You might also like